Top Abstract Purchase Related
Home
>
Node
>
Subnode

P-Aminobenzene sulphonyl morpholine, compound 82/208 a new anticonvulsant agent

Dua, P.R.; Ahuja, P.; Anand, N.

Indian Journal of Experimental Biology 32(10): 729-731

1994

ISSN/ISBN: 0019-5189
PMID: 7821984
Document Number: 436381
p-Aminobenzene sulphonyl morpholine, compound 82/208, was evaluated for acute toxicity and anti-convulsant action in mice against tonic seizures induced by supramaximal electroshock and pentylene tetrazole and strychnine induced seizures and for its effect on blood pressure and respiration in cat. Diphenyl hydantoin (DPH) was used as reference standard. Compound 82/208 exhibited anticonvulsant activity against electroshock induced seizures and PTZ induced tonic seizures in mice. The compound had several distinct advantages over DPH in experimental evaluation in mice.

Document emailed within 1 workday
Secure & encrypted payments

Dua, P.R.; Chatterji, S.K. 1981: Anticonvulsant activity of 3-p-chlorophenoxy-1-n (3,4 dimethoxy phenyl) piperazinopropanol-2 (compound 65/359) Indian Journal of Experimental Biology 19(11): 1047-1049
Stiff, D.D.; Zemaitis, M.A. 1990: Metabolism of the anticonvulsant agent zonisamide in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 888-894
Martin, S.W.; Bishop, F.E.; Kerr, B.M.; Moor, M.; Moore, M.; Sheffels, P.; Rashed, M.; Slatter, J.G.; Berthon-Cédille, L.; Lepage, F.; Descombe, J.J.; Picard, M.; Baillie, T.A.; Levy, R.H. 1997: Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(1): 40-46
Sreenivasulu, S.; Singh, M.M.; Dwivedi, A.; Setty, B.S.; Kamboj, V.P. 1992: Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent Indian Journal of Experimental Biology 30(11): 968-971
Paprocka, M.; Boratyński, J.; Duś, D.; Kuśnierczyk, H.; Radzikowski, C. 1997: Conjugation of the monoclonal antibody 17-1A with the nitroacridine compound C921 with the poly-L-lysine as an intermediate agent Archivum Immunologiae et Therapiae Experimentalis 45(4): 343-349
Lindl, T.; Heinl-Sawaya, M.C.; Cramer, H. 1976: Effects of compound 48/80, a histamine-releasing agent, on accumulation and release of cyclic AMP in various regions of rat brain in vitro Research Communications in Chemical Pathology and Pharmacology 13(1): 65-74
Christiansen, C.; Rødbro, P. 1979: Anticonvulsant-induced osteomalacia. Vitamin D metabolism disorders in epileptics on anticonvulsant therapy Ugeskrift for Laeger 141(5): 280-284
Graziani, G.; Tirone, F.; Barbadoro, E.; Testa, R. 1983: Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile Arzneimittel-Forschung 33(8): 1155-1160
Frey, O.R. 2001: Anticonvulsant weaning? how should anticonvulsant therapy be discontinued? Medizinische Monatsschrift für Pharmazeuten 24(8): 266
Kleniewska, D.; Maibach, H. 1980: Allergenicity of aminobenzene compounds: structure-function relationships Dermatosen in Beruf und Umwelt. Occupation and Environment 28(1): 11-13
Kleniewska, D.; Maibach, H. 1980: Allergenicity of aminobenzene compounds: structure-function relationships Dermatosen in Beruf und Umwelt. Occupation and Environment 28(1): 11-13
Wójcik, A.; Burek, G.; Kowalczyk, A. 1989: Toxic-dynamics of lead compound and zinc compound in the evaluation of experimental animal behavior Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 44: 71-76
Sharma, J.N.; Prasad, C.R.; Dhawan, B.N. 1977: Studies on 3-aminobenzo-6, 7-quinazoline-4-one (centazolone, compound 65/469), a new tranquillosedative compound: Part III--Assessment of central muscle relaxant activity Indian Journal of Experimental Biology 15(12): 1120-1124
Szadowska, A.; Kielek, M.B.; Szmigielska, H.; Kotelko, B. 1976: Central action of some new amide derivatives of morpholine and homomorpholine Acta Poloniae Pharmaceutica 33(3): 407-414
Youssef, A.F.; el-Shabouri, S.R.; Mohamed, F.A.; Rageh, A.M. 1986: Colorimetric determination of certain phenothiazine drugs by using morpholine and iodine-potassium iodide reagents Journal - Association of Official Analytical Chemists 69(3): 513-518
Kotelko, B.; Glinka, R. 1973: Synthesis of amide deriatives of morpholine and homomorpholine (hexahydrooxazepine-1,4) with potential pharmacological action Acta Poloniae Pharmaceutica 30(2): 135-143
Van Stee, E.W.; Sloane, R.A.; Simmons, J.E.; Brunnemann, K.D. 1983: In vivo formation of N-nitrosomorpholine in CD-1 mice exposed by inhalation to nitrogen dioxide and by gavage to morpholine Journal of the National Cancer Institute 70(2): 375-379
Prasad, C.R.; Sharma, J.N.; Dhawan, B.N. 1977: Studies on 3-aminobenzo-6, 7-quinazoline-4-one (centazolone, compound 65/469), a new tranquillosedative compound: Part II--Assessment of tranquillosedative activity Indian Journal of Experimental Biology 15(12): 1115-1119
Picciòla, G.; Ravenna, F.; Carenini, G.; Manzardo, S.; Gentili, P. 1981: Heterocyclic compounds containing a 4-aminophenylalkanoic acid group with potential antiinflammatory activity. II. 2-Substituted morpholine derivatives Il Farmaco; Edizione Scientifica 36(1): 47-60
Marchetti, E.; Bergesi, G. 1970: Distribution and metabolic fate of morphethylbutyne in rats (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester) Archives Internationales de Pharmacodynamie et de Therapie 184(2): 245-251